Roche and KlinRisk have secured CE mark approval for their AI-driven risk stratification tool, designed for evaluating the progression of kidney function decline. The new tool, a part of Roche's newly ...

Chronic kidney disease (CKD) has emerged as a global health challenge, largely due to its profound impact on mineral metabolism. Disruption of the tightly regulated balance of phosphate, calcium and ...

Credit: Getty Images Serum levels may be a less sensitive marker for nutritional status because of rapid changes due to kidney filtration, albumin transport, or hormonal control. For optimal outcomes, ...

Aptar Digital Health has signed a licensing agreement with AstraZeneca for detecting renal, cardiovascular and metabolic conditions such as chronic kidney disease (CKD), using the latter’s AI-driven ...

Credit: Getty Images In advanced CKD stages, patients are not only at risk of low bone mass but also of poor bone quality. Abnormalities in phosphorus, iPTH, and FGF-23 levels can increase the risk ...